FDA Inspection
Circadia by Dr Pugliese, Inc.Circadia by Dr Pugliese, Inc. – FDA Inspection, Apr 1, 2022
Record Details
This FDA Inspection record concerns Circadia by Dr Pugliese, Inc., with an inspection on April 1, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 1, 2022
- Product Type
- Drugs
View Company Profile
ID · 66f049fe-bc0b-42bc-8764-cf2bd2b214fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1166041
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.84(d)(2)Establish reliability of supplier"s C of A
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.166(a)Lack of written stability program
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.